Drug Delivery Devices - Africa

Africa

Highlights

In Africa, revenue in the Drug Delivery Devices market market is projected to reach US$406.10m in 2024.
This revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 5.51%, leading to a market volume of US$531.10m by 2029.
When compared globally, the majority of revenue will be generated the United States, which is anticipated to reach US$15.01bn in 2024.
The African market for drug delivery devices is witnessing a surge in innovative solutions, driven by increasing healthcare accessibility and evolving patient needs.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market within the Medical Devices sector in Africa is witnessing mild growth, influenced by factors such as limited healthcare infrastructure, regulatory challenges, and rising demand for accessible healthcare solutions among the population.

Customer preferences: In Africa, there is a growing preference for personalized and user-friendly drug delivery devices, reflecting a shift towards more patient-centered healthcare. Consumers are increasingly valuing solutions that cater to their specific needs, influenced by cultural beliefs around medication and health practices. Additionally, as urbanization rises, there is a demand for more efficient and portable delivery systems that align with fast-paced lifestyles. This trend is bolstered by an increase in health awareness and a desire for innovative solutions that simplify treatment adherence and improve health outcomes.

Trends in the market: In Africa, the Drug Delivery Devices Market is experiencing a notable shift towards innovative, user-centric solutions that enhance patient engagement and adherence. There is an increasing demand for devices that are not only efficient but also portable, catering to the urban population's fast-paced lifestyle. This trend is significant as it reflects a broader movement towards personalized healthcare, influenced by rising health awareness and cultural attitudes toward treatment. For industry stakeholders, these developments present opportunities to innovate and tailor products to meet diverse patient needs, ultimately improving health outcomes across the continent.

Local special circumstances: In Africa, the Drug Delivery Devices Market is shaped by diverse geographical and cultural factors that differentiate it from other regions. The continent's vast rural areas often face healthcare access challenges, driving demand for portable and easy-to-use delivery devices. Additionally, cultural attitudes towards traditional medicine influence patient preferences, fostering a blend of conventional and modern treatment methods. Regulatory frameworks vary significantly across countries, impacting the speed of innovation and market entry for new products. These unique elements create a dynamic landscape for stakeholders to navigate, ultimately shaping product development and marketing strategies.

Underlying macroeconomic factors: The Drug Delivery Devices Market in Africa is influenced by macroeconomic factors such as economic stability, investment in healthcare infrastructure, and changing demographics. Countries experiencing economic growth are more likely to allocate resources toward improving healthcare systems, which enhances access to advanced drug delivery technologies. Additionally, inflation rates and currency fluctuations can impact the affordability and availability of these devices. The rising incidence of non-communicable diseases further drives demand for innovative delivery solutions. As healthcare policies evolve, public-private partnerships are becoming crucial for fostering innovation and ensuring that devices meet local needs effectively.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.